Biomineralization: A new tool for developing eco-sustainable Ti-doped hydroxyapatite-based hybrid UV filters.


Journal

Biomaterials advances
ISSN: 2772-9508
Titre abrégé: Biomater Adv
Pays: Netherlands
ID NLM: 9918383886206676

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 25 11 2022
revised: 10 05 2023
accepted: 12 05 2023
medline: 15 6 2023
pubmed: 20 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

It is well known that the prolonged exposure to UV radiation from sunlight can compromise human health and is particularly damaging to the skin, leading to sunburn, photo-aging and skin cancer. Sunscreen formulations containing UV-filters present a barrier against solar UV and help to mitigate the harmful effects however, concern about their safety for both human and environmental health is still a much-debated topic. EC regulations classify UV-filters depending on their chemical nature, particle size, and mechanism of action. Furthermore, it regulates their use in cosmetic products with specific limitations in terms of concentration (organic UV filters) and particle size and surface modification to reduce their photo-activity (mineral UV filters). The regulations have prompted researchers to identify new materials that show promise for use in sunscreens. In this work, biomimetic hybrid materials composed of titanium-doped hydroxyapatite (TiHA) grown on two different organic templates, derived from animal (gelatin - from pig skin) and vegetable (alginate - from algae) sources. These novel materials were developed and characterized to obtain sustainable UV-filters as a safer alternative for both human and ecosystem health. This 'biomineralization' process yielded TiHA nanoparticles that demonstrated high UV reflectance, low photoactivity, good biocompatibility and an aggregate morphology which prevents dermal penetration. The materials are safe for topical application and for the marine environment; moreover, they can protect organic sunscreen components from photodegradation and yield long-lasting protection.

Identifiants

pubmed: 37207586
pii: S2772-9508(23)00197-8
doi: 10.1016/j.bioadv.2023.213474
pii:
doi:

Substances chimiques

Hydroxyapatites 0
Sunscreening Agents 0
Titanium D1JT611TNE
Gelatin 9000-70-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213474

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Elisabetta Campodoni (E)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy. Electronic address: elisabetta.campodoni@istec.cnr.it.

Margherita Montanari (M)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Chiara Artusi (C)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Linda Bergamini (L)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Giada Bassi (G)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Elena Destro (E)

Department of Chemistry, University of Turin, Via Pietro Giuria 7, 10125 Turin, Italy.

Ivana Fenoglio (I)

Department of Chemistry, University of Turin, Via Pietro Giuria 7, 10125 Turin, Italy.

Silvia Panseri (S)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Anna Tampieri (A)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Alessandra Sanson (A)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.

Monica Sandri (M)

Institute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy. Electronic address: monica.sandri@istec.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH